CD19 and acute lymphoblastic leukemia: Samples from patients with KMT2A gene rearrangements were analyzed separately, as this subgroup of BCP-ALL is known for immunophenotypic peculiarities that can hamper MFC-MRD detection [43,44], especially if CD19 is lost.